Smoking Clinical Trial
Official title:
'The Factors Associated With the Formation of Nasal Polyp'
Nasal polyp is a significant health problem with a prevalence of 4%. It is increased in
patients with asthma (7-15%), Cystic fibrosis (39-56%) or aspirin intolerance (36-96%).The
quality of life (QOL) is worse than in patients suffering from hypertension, migraine,
angina pectoris and head & neck cancer as per a previous study by Videler WJM et al.QOL is
in comparison to chronic obstructive pulmonary disease.The reason why it develops in some
and not in others remains unknown despite the disease being present for centuries.A definite
relationship exists in patients with 'Sampter triad': Asthma, non steroidal
anti-inflammatory drug sensitivity and nasal polyps. But not all patients with NSAID
sensitivity have nasal polyps and vice verse.
Etiology is largely unknown despite the disease being present for centuries. Although the
factors like wood stove exposure, smoking, allergic rhinitis, rhino sinusitis have been
strongly implicated in literature from various studies, most data available is on ethmoidal
polyps.The present study is an attempt to study the association of important risk factors
with both antrochoanal(AC) and ethmoidal nasal polyps(EP).One study found that a
significantly smaller proportion of the population with polyps were smokers compared to the
unselected population (15% v/s 35%). But this is not confirmed by other studies.
Seven percent of asthma patients have nasal polyps and in non atopic asthma and late onset
asthma, polyps are diagnosed more frequently (10-15%).Eosinophil numbers are significantly
higher in nasal polyp tissue and further increased in patients with co-morbid asthma and
aspirin sensitivity.
Nasal colonization in increased amounts was found by Staphylococcus aureus and presence of
specific Immunoglobulin E directed against S.aureus enterotoxins was found. Rates of
colonization and IgE presence in nasal polyp tissue were increased in subjects with nasal
polyp associated with co-morbid asthma and aspirin sensitivity.
Nasal polyps are frequently found to run in families, suggesting a hereditary or with shared
environmental factor. In the study by Rugina et al., more than half of 224 nasal polyp
patients (52%) had a positive family history while the study by Greisener et.al, reported
14% of family history strongly suggesting hereditary factors in the pathogenesis of nasal
polyps.
Some studies have found environmental factors like smoking and those using wood stove as a
primary source of heating with the development of nasal polyps. The studies are contrasting.
There is presently a need of understanding the differences in the pathogenesis of
antrochoanal polyp and ethmoidal nasal polyp clearly.There are hardly any concrete research
performed on them to note the differences in the etiology and their pathogenesis. Hence the
study is undertaken to extensively study the etiologies responsible for them and to note the
differences.
The present study involves two parts. A case control study wherein the association of nasal
polyps with various risk factors like smoking, wood stove exposure, allergic rhinitis, non
vegetarian diet intake, rhino sinusitis, deviated nasal septum, occupational dust exposure
and eosinophilia.This will be studied individually for antrochoanal and ethmoidal nasal
polyps.Again the same will be studied with respect to the recurrent and non recurrent
polyps.
A descriptive study focuses on the nasal polyp occurrence with respect to the age, sex,
religion, socioeconomic status, urban or rural preponderance,overcrowding, aspirin
intolerance, family history etc.
The results will be studies after calculating the odds ratio and the chi square test for
whatever data is available. Interpretation will be performed subsequently.
Gene expression profiling would be performed to study the differences in gene expression
levels between AC and EP s with respect to risk factors and morphological
characteristics.Mutational analysis will be performed to identify mutations in selected
genes.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02649556 -
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT03170752 -
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)
|
N/A | |
Completed |
NCT03305978 -
Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.
|
N/A | |
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Completed |
NCT06105424 -
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
|
N/A | |
Active, not recruiting |
NCT02752022 -
Monitoring the Transition From Smoking to E-cigarettes
|
||
Completed |
NCT04340830 -
The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants
|
N/A | |
Completed |
NCT02901171 -
The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02912000 -
TEACH: Technology Evaluation to Address Child Health
|
N/A | |
Completed |
NCT02949648 -
Electronic Cigarette Use and Quitting in Youth
|
N/A | |
Completed |
NCT02246114 -
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
|
N/A | |
Completed |
NCT02945371 -
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
|
N/A | |
Completed |
NCT01898507 -
Nicotine Metabolism and Low Nicotine Cigarettes
|
N/A | |
Completed |
NCT02008292 -
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
|
N/A | |
Completed |
NCT01954407 -
Young Adults' Responses to Anti-smoking Messages
|
N/A |